Stibophen: Difference between revisions
Created page with "{{Drugbox | Watchedfields = changed | verifiedrevid = 387475262 | IUPAC_name = Pentasodium 2-(2-oxido-3,5-disulfonatophenoxy)-1,3,2-benzodioxastibole-5,7-disulfonate | image =..." |
m Protected "Stibophen": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 38: | Line 38: | ||
| smiles = C1=C(C=C2C(=C1S(=O)(=O)[O-])O[Sb](O2)OC3=CC(=CC(=C3[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+] | | smiles = C1=C(C=C2C(=C1S(=O)(=O)[O-])O[Sb](O2)OC3=CC(=CC(=C3[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+] | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Stibophen''' is an [[anthelmintic]] classified as antimony compound and used as treatment of [[schistosomiasis]]<ref>{{cite pmid|13268811}}</ref> by [[intramuscular injection]]. | '''Stibophen''' is an [[anthelmintic]] classified as antimony compound and used as treatment of [[schistosomiasis]]<ref>{{cite pmid|13268811}}</ref> by [[intramuscular injection]]. | ||
Line 50: | Line 54: | ||
[[Category:Antiparasitic agents]] | [[Category:Antiparasitic agents]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 17:10, 20 August 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C12H4Na5O16S4Sb |
Molar mass | 769.12 g/mol |
3D model (JSmol) | |
| |
(verify) |
WikiDoc Resources for Stibophen |
Articles |
---|
Most recent articles on Stibophen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Stibophen at Clinical Trials.gov Clinical Trials on Stibophen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Stibophen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Stibophen Discussion groups on Stibophen Directions to Hospitals Treating Stibophen Risk calculators and risk factors for Stibophen
|
Healthcare Provider Resources |
Causes & Risk Factors for Stibophen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Stibophen is an anthelmintic classified as antimony compound and used as treatment of schistosomiasis[1] by intramuscular injection.
Mechanism of action
Stibophen inhibits the enzyme phosphofructokinase, which the worms need for glycolysis,[2] at least partly by binding to the sulfhydryl (–SH) group of the enzyme.[3] Inhibiting glycolysis paralyzes the worms, which lose their hold on the wall of mesenteric veins and undergo hepatic shift, die, and are phagocytosed by liver cells.[citation needed]
References
- ↑ PMID 13268811 (PMID 13268811)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 13446367 (PMID 13446367)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 8898332 (PMID 8898332)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
- Pages with script errors
- Pages with incomplete PMID references
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- All articles with unsourced statements
- Articles with unsourced statements from December 2013
- Articles with invalid date parameter in template
- Antiparasitic agents
- Drug